Livforsakringsbolaget Skandia’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,126
| Closed | -$161K | – | 455 |
|
|
2026
Q1 | $161K | Hold |
2,126
| – | – | 0.01% | 357 |
|
|
2025
Q4 | $158K | Hold |
2,126
| – | – | 0.01% | 382 |
|
|
2025
Q3 | $143K | Sell |
2,126
-700
| -25% | -$46.5K | 0.01% | 423 |
|
|
2025
Q2 | $184K | Hold |
2,826
| – | – | 0.01% | 400 |
|
|
2025
Q1 | $175K | Hold |
2,826
| – | – | 0.01% | 417 |
|
|
2024
Q4 | $204K | Hold |
2,826
| – | – | 0.01% | 390 |
|
|
2024
Q3 | $230K | Buy |
2,826
+2,036
| +258% | +$163K | 0.01% | 388 |
|
|
2024
Q2 | $58.7K | Hold |
790
| – | – | ﹤0.01% | 361 |
|
|
2024
Q1 | $61.6K | Hold |
790
| – | – | 0.01% | 378 |
|
|
2023
Q4 | $56.4K | Buy |
790
+468
| +145% | +$32.6K | 0.01% | 378 |
|
|
2023
Q3 | $22.3K | Hold |
322
| – | – | ﹤0.01% | 451 |
|
|
2023
Q2 | $26.1K | Hold |
322
| – | – | ﹤0.01% | 442 |
|
|
2023
Q1 | $26K | Hold |
322
| – | – | ﹤0.01% | 439 |
|
|
2022
Q4 | $24.1K | Hold |
322
| – | – | ﹤0.01% | 442 |
|
|
2022
Q3 | $21K | Sell |
322
-1,300
| -80% | -$90K | ﹤0.01% | 453 |
|
|
2022
Q2 | $112K | Sell |
1,622
-9,300
| -85% | -$690K | 0.01% | 440 |
|
|
2022
Q1 | $839K | Hold |
10,922
| – | – | 0.06% | 210 |
|
|
2021
Q4 | $836K | Hold |
10,922
| – | – | 0.05% | 218 |
|
|
2021
Q3 | $806K | Hold |
10,922
| – | – | 0.05% | 260 |
|
|
2021
Q2 | $729K | Hold |
10,922
| – | – | 0.04% | 289 |
|
|
2021
Q1 | $813K | Hold |
10,922
| – | – | 0.06% | 248 |
|
|
2020
Q4 | $796K | Buy |
10,922
+1,300
| +14% | +$91.8K | 0.07% | 233 |
|
|
2020
Q3 | $639K | Buy |
9,622
+7,000
| +267% | +$443K | 0.07% | 217 |
|
|
2020
Q2 | $149K | Hold |
2,622
| – | – | 0.02% | 431 |
|
|
2020
Q1 | $92K | Hold |
2,622
| – | – | 0.01% | 497 |
|
|
2019
Q4 | $137K | Sell |
2,622
-1,300
| -33% | -$64.7K | 0.02% | 442 |
|
|
2019
Q3 | $198K | Hold |
3,922
| – | – | 0.02% | 422 |
|
|
2019
Q2 | $188K | Buy |
3,922
+1,500
| +62% | +$69.4K | 0.02% | 414 |
|
|
2019
Q1 | $117K | Hold |
2,422
| – | – | 0.02% | 457 |
|
|
2018
Q4 | $100K | Hold |
2,422
| – | – | 0.01% | 456 |
|
|
2018
Q3 | $99K | Sell |
2,422
-1,800
| -43% | -$72.8K | 0.01% | 548 |
|
|
2018
Q2 | $168K | Hold |
4,222
| – | – | 0.02% | 558 |
|
|
2018
Q1 | $158K | Hold |
4,222
| – | – | 0.02% | 568 |
|
|
2017
Q4 | $180K | Sell |
4,222
-600
| -12% | -$23.9K | 0.02% | 510 |
|
|
2017
Q3 | $177K | Hold |
4,822
| – | – | 0.02% | 563 |
|
|
2017
Q2 | $219K | Hold |
4,822
| – | – | 0.02% | 494 |
|
|
2017
Q1 | $205K | Sell |
4,822
-6,800
| -59% | -$277K | 0.02% | 510 |
|
|
2016
Q4 | $466 | Sell |
11,622
-40,881
| -78% | -$1.58M | 0.02% | 579 |
|
|
2016
Q3 | $6.12M | Buy |
52,503
+28,781
| +121% | +$1.09M | 0.3% | 70 |
|
|
2016
Q2 | $821K | Hold |
23,722
| – | – | 0.04% | 473 |
|
|
2016
Q1 | $818K | Hold |
23,722
| – | – | 0.04% | 473 |
|
|
2015
Q4 | $918K | Hold |
23,722
| – | – | 0.04% | 427 |
|
|
2015
Q3 | $928K | Hold |
23,722
| – | – | 0.05% | 452 |
|
|
2015
Q2 | $903K | Hold |
23,722
| – | – | 0.04% | 491 |
|
|
2015
Q1 | $783K | Sell |
23,722
-15,500
| -40% | -$476K | 0.04% | 535 |
|
|
2014
Q4 | $1.05M | Hold |
39,222
| – | – | 0.05% | 504 |
|
|
2014
Q3 | $954K | Hold |
39,222
| – | – | 0.04% | 528 |
|
|
2014
Q2 | $994K | Hold |
39,222
| – | – | 0.04% | 529 |
|
|
2014
Q1 | $843K | Buy |
+39,222
| New | +$846K | 0.03% | 563 |
|
Other funds holding HOLX
Livforsakringsbolaget Skandia's HOLX Position: Q2 2026 in Review
Livforsakringsbolaget Skandia sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,126 shares — an estimated $161K sold.
Livforsakringsbolaget Skandia first reported a position in HOLX in Q1 2014 and held it in 49 quarters. The position peaked at $6.12M in Q3 2016. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Livforsakringsbolaget Skandia reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Livforsakringsbolaget Skandia sold 2,126 Hologic shares in Q2 2026, an estimated $161K.
- Livforsakringsbolaget Skandia first reported a position in Hologic in Q1 2014 and held it in 49 quarters.
- Livforsakringsbolaget Skandia's Hologic position peaked at $6.12M in Q3 2016.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Livforsakringsbolaget Skandia's 13F filing for Q2 2026, filed 18 Aug 2026.